Erik Briers holds a doctorate in Chemistry (1979) from the University of Leuven, Belgium. After teaching chemistry and physics, Briers served from 1979 until 1980 as the Head of the department for biochemistry, at the Central Medical Laboratory in Antwerp, Belgium.
From 1980 to 1982 Briers worked as Head of scientific services for bioMérieux. In 1982 Briers founded a biotech company ECO-BIO. ECO-BIO was an in vitro diagnostics company specialised in microbiology and immunology. One of the products for the detection of Aspergillus antigens (galactomannan) Dr Briers developed has FDA approval.
Since 1990 Briers is CEO of Beta Ventures, consulting the in vitro diagnostics industry and publisher of specialised media – Focus Diagnostica.
Today, Erik Briers is a guest lecturer for the subject “Trends and Innovations in the Biomedical Sector” within the Master study programme Bio-Engineering at the University of Leuven Faculty of Engineering Technology since 2009 and science and medical writer.
Doctor Briers strong social involvement within patient organisations began after his own prostate cancer diagnosis in 2001 and successful radical prostatectomy treatment with no signs of recurrences until today.
He joined the Belgian patient support group “Us Too Belgium” and is one of the founders of EUROPA UOMO. Today he is prostate cancer advocate and editor of the patient magazine “PROSTAATinfo”.He was the Executive Director of the European Cancer Patient Coalition (ECPC) (2012-2013) and Executive Director ad interim of EPPOSI (European platform for patient organisations science and industry) a multi-stakeholder think tank in health policy-making in 2014.